Latest Articles
-
Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte
Volume 20 Issue 1
Author(s): Tiantian Wang, Xijie Yu* and Chengqi He*
Pages: 1-15 (15) -
Bacterial Multidrug Efflux Proteins: A Major Mechanism of Antimicrobial Resistance
Volume 20 Issue 1
Author(s): Irshad Ahmad, Nighat Nawaz, Fatemeh Karimi Dermani, Alisa Khodadadi Kohlan, Massoud Saidijam and Simon G. Patching*
Pages: 16-28 (13)
Free -
Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System
Volume 20 Issue 1
Author(s): Ana C.N. Oliveira, Joana Fernandes, Anabela Goncalves, Andreia C. Gomes* and M.E.C.D. Real Oliveira*
Pages: 29-50 (22) -
Toll-Like Receptor 4 and Heat-Shock Protein 70: Is it a New Target Pathway for Diabetic Vasculopathies?
Volume 20 Issue 1
Author(s): Amanda Almeida de Oliveira, R. Clinton Webb and Kenia Pedrosa Nunes*
Pages: 51-59 (9) -
“Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae”
Volume 20 Issue 1
Author(s): Abdul Mannan Baig*
Pages: 60-69 (10) -
DNA Related Enzymes as Molecular Targets for Antiviral and Antitumoral Chemotherapy. A Natural Overview of the Current Perspectives
Volume 20 Issue 1
Author(s): Hugo A. Garro* and Carlos R. Pungitore
Pages: 70-80 (11) -
The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy
Volume 20 Issue 1
Author(s): Carlos G. Ferreira, Andrea Nicolini*, Liliana Dalurzo, Stephen Stefani, Vanessa Teiche and Natasha Leighl
Pages: 81-86 (6) -
Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications
Volume 20 Issue 1
Author(s): Claudia Arenaccio, Chiara Chiozzini, Flavia Ferrantelli, Patrizia Leone, Eleonora Olivetta and Maurizio Federico*
Pages: 87-95 (9) -
Natural Products Modulating Autophagy Pathway Against the Pathogenesis of Diabetes Mellitus
Volume 20 Issue 1
Author(s): Linghuan Li, Jiameng Qi and Hanbing Li*
Pages: 96-110 (15) -
Acid-Sensing Ion Channels Structural Aspects, Pathophysiological Importance and Experimental Mutational Data Available Across Various Species to Target Human ASIC1
Volume 20 Issue 1
Author(s): Anurag Singh Chauhan, Ganesh Chandra Sahoo, Manas Ranjan Dikhit* and Pradeep Das*
Pages: 111-121 (11) -
Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research
Volume 20 Issue 1
Author(s): Agnieszka Jankowska, Artur Świerczek, Elżbieta Wyska, Alicja Gawalska, Adam Bucki, Maciej Pawłowski and Grażyna Chłoń-Rzepa*
Pages: 122-143 (22)
Endorsement(s)
"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."
Jean-Marie Lehn
Nobel Laureate
"Thanks everybody. We are happy to get our paper published in your esteemed journal “current drug targets "
Hatta Sidi
Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan, Kuala Lumpur, Malaysia
Announcements
About the Publisher
Bentham Science: An Introduction
We have been serving the needs of STM field since 1992 and publish 117 titles, fulfilling the information needs for the Pharmaceutical and Biomedical research community. We are publishers of many high impact factor Journals and eBooks.
Subscription Information:
All Journals are available online. For information on the Journals and how to order, please visit our web site at: www.benthamscience.com/journal/price-order.php and select "Prices and Ordering" or contact our subscription department at: subscriptions@benthamscience.org
Open Access:
Bentham Science currently offers authors the choice of publishing their articles as open access. Please refer to the Journal instructions for authors for details.
Indexed in
